Clinical Trials Results - National Cancer Institute

Skip to content

National Cancer Institute
U.S. National Institutes of Health | www.cancer.gov


	Clinical Trials Search Results

	Quick Links


	Director's Corner Dictionary of Cancer Terms NCI Drug Dictionary Funding Opportunities NCI Publications Advisory Boards and Groups Science Serving People Español

Questions about cancer?


	1-800-4-CANCER

	LiveHelp® online chat

	NCI Highlights


	Virtual and Standard Colonoscopy Both Accurate Denosumab May Help Prevent Bone Loss Past Highlights



Results: 1 -10 of 21 Show results per page	View Search Criteria \| Help With Results


Sort By:	Version:	Format:


1.		Phase III Combination Chemotherapy with ARA-C/RBD/VCR/PRED for Adults with Chronic Myelogenous Leukemia

	Phase				Type				Status				Age				Sponsor				Protocol IDs

	Phase III				Treatment				Closed				under 50								MDA-DT-7978 NCI-V84-0021


2.		Late Intensification with CROP (CTX/RBD/VCR/PRED) with or without Active Specific Immunotherapy for AML

	Phase				Type				Status				Age				Sponsor				Protocol IDs

	Phase II				Treatment				Closed				under 50								MDA-DT-7745


3.		Phase II Chemotherapy with Rubidazone for Children with Refractory Acute Lymphoblastic or Acute Myelogenous Leukemia

	Phase				Type				Status				Age				Sponsor				Protocol IDs

	Phase II				Treatment				Closed				under 21				NCI				POG-7818 MDAR-313


4.		Phase II Chemotherapy with Rubidazone for Solid Tumors in Children

	Phase				Type				Status				Age				Sponsor				Protocol IDs

	Phase II				Treatment				Closed				21 and under				NCI				POG-7843

Last Modified: 5/2/2007


5.		Phase II Combination Chemotherapy with Rubidazone and DTIC for Advanced Sarcomas and Mesotheliomas

	Phase				Type				Status				Age				Sponsor				Protocol IDs

	Phase II				Treatment				Closed				no age specified				NCI				SWOG-7625 MDAR-134


6.		Phase II Combination Chemotherapy with ROAP - RBD/VCR/ARA-C/PRED for Acute Leukemia

	Phase				Type				Status				Age				Sponsor				Protocol IDs

	Phase II				Treatment				Completed				over 50				NCI				SWOG-7626


7.		Phase II Chemotherapy with Rubidazone for Previously Treated Adults with Acute Leukemia or CML Blast Transformation

	Phase				Type				Status				Age				Sponsor				Protocol IDs

	Phase II				Treatment				Completed				over 18				NCI				SWOG-7633 MDAR-193


8.		Phase II Chemotherapy with Rubidazone for Advanced Breast Cancer

	Phase				Type				Status				Age				Sponsor				Protocol IDs

	Phase II				Treatment				Closed				65 and under				NCI				SWOG-7726


9.		Phase II Chemotherapy with Rubidazone for Lymphoma in Relapsing Patients Previously Untreated with Anthracycline Derivatives

	Phase				Type				Status				Age				Sponsor				Protocol IDs

	Phase II				Treatment				Closed				no age specified				NCI				SWOG-7734

Last Modified: 9/11/2007


10.		Phase II ROAP (RBD/VCR/ARA-C/PRED) vs ADOAP (ADR/VCR/ARA-C/PRED) with Intensification and/or Immunotherapy for Acute Leukemia

	Phase				Type				Status				Age				Sponsor				Protocol IDs

	Phase II				Treatment				Completed				over 15				NCI				SWOG-7823/24/25/26

Select All on One Page


					1 2 3 Next >

| | | | | | | |

A Service of the National Cancer Institute